CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2016; 37(04): 305
DOI: 10.4103/0971-5851.195746
LETTERS TO EDITOR

Folate supplementation in transfusion-dependent thalassemia: Do we really need such high doses?

Gaurav Tripathi
Department of Pediatric Hematology Oncology, Indraprastha Apollo Hospital, New Delhi, India
,
Manas Kalra
Department of Pediatric Hematology Oncology, Indraprastha Apollo Hospital, New Delhi, India
,
Amita Mahajan
Department of Pediatric Hematology Oncology, Indraprastha Apollo Hospital, New Delhi, India
› Author Affiliations
Financial support and sponsorship Nil.


Publication History

Article published online:
12 July 2021

© 2016. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Mojtahedzadeh F, Kosaryan M, Mahdavi MR, Akbari J. The effect of folic acid supplementation in beta-thalassemia major: A randomized placebo-controlled clinical trial. Arch Iran Med 2006;9:266-8.
  • 2 Kumar R, Saraya AK, Choudhyr VP, Sundaram KR, Kailash S, Sehgal AK. Vitamin B12, folate, and iron studies in homozygous beta thalassemia. Am J Clin Pathol 1985;84:668-71.
  • 3 Castagna PC, Fedeli F, Fusco AM, Montani L, Radaelli F, Tartara R. Behavior of blood folate in children with thalassemia major under transfusion therapy and in thalassemia trait. Acta Vitaminol Enzymol 1984;6:183-8.